Stay updated on Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.

Latest updates to the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page
- Check5 days agoChange DetectedAdded Abbotsford, British Columbia as a study location and updated the status to 'Results Submitted' while removing the previous 'No Results Posted' status.SummaryDifference0.0%

- Check12 days agoChange DetectedUpdated the Locations entry from Napoli, Campania, Italy, 80131 to Naples, Campania, Italy, 80131.SummaryDifference0.0%

- Check20 days agoChange DetectedThe site revision has been updated to v3.5.0, replacing v3.4.3.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.4.2 was added. The funding-lapse notice and the earlier Revision: v3.4.1 were removed.SummaryDifference0.2%

- Check63 days agoChange DetectedNotice was added informing users of a lapse in government funding with a statement that the NIH Clinical Center is open and links for status updates (cc.nih.gov and opm.gov). The page's revision marker changed from v3.4.0 to v3.4.1.SummaryDifference0.2%

Stay in the know with updates to Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.